Vietnam's rising burden of cancer, a result of the increasingly urbanised and ageing population, will provide commercial opportunities to pharmaceutical firms. However, we highlight there are a number of challenges to firms' growth prospects, such as the low level of absolute healthcare expenditure, infrastructure deficiencies and insufficient human resources for healthcare.
Vietnam's reliance on imported drugs (both generic and patented) will continue to provide ample commercial opportunities for foreign drugmakers. However, the population's concerns over drug quality means that only companies with relatively positive branding are likely to succeed in the Vietnamese pharmaceutical market. In addition, downside risks for foreign generic drug manufacturers include...
The upgrade to our private healthcare forecast stems largely from the Vietnamese government's plan to pass hospital operating costs to patients. We highlight that this is potentially regressive should hospitals attempt to profit from such policies. Nevertheless, we remain largely optimistic towards Vietnam's healthcare sector as it is seeking to implement universal healthcare for its population...
Complete the trial form to receive a free issue of Pharma and Healthcare Insight sent to your email address. The Pharma and Healthcare Insight provides you with in-depth country by country data, analysis and forecasts.
START A FREE TRIAL TODAY
STEP 2: SELECT PRODUCTS
Please select the free products you would like to trial:
Thank you for your interest in Pharma and Healthcare Insight
You will shortly receive an e-mail with link(s) to a full version of the newsletter(s) you selected. A member of our Client Services team will be in touch soon to receive your feedback on the newsletters and arrange a convenient time for a free demonstration of the full service. If your enquiry is urgent, please email our team here
Business Monitor International -
A Fitch Group Company